BioPharmaChem Ireland’s (BPCI) strategy document 2019-2023 was titled “Ireland–the Global BioPharmaChem Location of Choice” and was a clear recognition that Ireland had made significant strides in the previous decade to become a globally recognised centre of excellence for innovation and development in biopharmaceutical, pharmaceutical & chemical manufacture and supply.

The sector has continued to thrive and in 2021, the industry became worth  €100 billion to the economy in terms of exports, there are now more than 84,000 highly skilled people directly & indirectly employed in the sector and the expectation is that this will increase by up to 10,000 jobs over the next 5 years. The sector has also continued to be very successful in attracting international capital investments in the last decade – much of this in the manufacture and development of biotech products.

Download report